Branded Legacy Eliminates $1 Million in Legacy Convertible Debt, Strengthening Financial Position

Branded Legacy, Inc. (OTC: BLEG) announced the successful elimination of approximately $1 million in legacy convertible debt originating under prior management. The company's new leadership team under Dr. Jamie Forrest, PhD, MPH conducted a comprehensive review of historical obligations and negotiated highly favorable terms with legacy debt holders to retire the instruments. This strategic move results in an immediate improvement to the balance sheet, a reduction in future dilution risk, and increased financial flexibility for shareholders.

The company stated that it is continuing to work with OTC Markets Group to update the issuer profile and disclosures on OTCMarkets.com. Management is focused on completing remaining requirements to remove the Yield Sign while maintaining a policy of clear, factual, and milestone-based communications. The debt elimination represents a significant step in the company's financial restructuring efforts under its new leadership direction.

Branded Legacy operates as a forward-thinking holdings company dedicated to pioneering solutions in addiction treatment and harm reduction. Through its subsidiary, BioLegacy Evaluative Group, and strategic collaborations with leading institutions like McMaster University and Stanford University, the company drives transformative research and innovation. With a state-of-the-art GMP manufacturing facility in Vancouver, Branded Legacy leverages advanced production capabilities to deliver cutting-edge products, positioning itself as a leader in addressing critical public health challenges.

The company maintains an online presence where investors can find additional information about its operations and strategic direction at https://BrandedLegacy.com. This debt elimination comes as part of broader corporate initiatives to strengthen the company's financial foundation and enhance shareholder value through improved capital structure and reduced financial liabilities.